Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
European Urology Focus|December 9, 2023
Systematic Review and Meta-analysis of Minimally Invasive Procedures for Surgical Inguinal Nodal Staging in Penile CarcinomaIsabella Greco, Sergio Fernandez-Pello, Vasileios I Sakalis, et al.
European Urology|July 15, 2026
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2026 Update: Treatment of Relapsing and Metastatic Prostate CancerDerya Tilki, Roderick C N van den Bergh, Erik Briers, et al.
European Urology|July 15, 2026
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2026 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative IntentPhilip Cornford, Roderick C N van den Bergh, Erik Briers, et al.
European Urology|March 11, 2023
European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 UpdateOscar R Brouwer, Maarten Albersen, Arie Parnham, et al.
European Urology|May 19, 2023
Management of Lymph Node-positive Penile Cancer: A Systematic ReviewAshwin Sachdeva, Luke McGuinness, Łukasz Zapala, et al.
BJU International|November 13, 2020
Management of patients who opt for radical prostatectomy during the coronavirus disease 2019 (COVID-19) pandemic: an international accelerated consensus statementZafer Tandogdu, Justin Collins, Greg Shaw, et al.
The Lancet. Digital Health|June 4, 2025
External validation of a digital pathology-based multimodal artificial intelligence-derived prognostic model in patients with advanced prostate cancer starting long-term androgen deprivation therapy: a post-hoc ancillary biomarker study of four phase 3 randomised controlled trials of the STAMPEDE platform protocolCharles T A Parker, Larissa Mendes, Vinnie Y T Liu, et al.
Cell|August 27, 2025
Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancersEmily Grist, Peter Dutey-Magni, Marina A Parry, et al.
Research Square|February 17, 2023
Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trialMarina A Parry, Emily Grist, Larissa Mendes, et al.
The Lancet. Oncology|July 10, 2025
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocolSilke Gillessen, Laura Murphy, Nicholas D James, et al.
Pageof 6